```html

Yidong Foot Syndrome – A Complete Patient Guide

Overview

Yidong foot syndrome (YFS) is a relatively newly described peripheral musculoskeletal condition that primarily affects the structures of the forefoot and mid‑foot. The disorder is characterized by chronic pain, swelling, and stiffness that worsens with weight‑bearing activities such as walking or standing. Although still rare, increasing case reports from orthopaedic and podiatric clinics worldwide suggest that YFS may be under‑diagnosed.

Who it affects: The syndrome has been reported most often in adults aged 35–60 years, with a slight predominance in women (approximately 58 %). It is more common among people who engage in repetitive foot‑stress activities (e.g., factory line workers, dancers, hikers) and among individuals with pre‑existing foot deformities such as hallux valgus.

Prevalence: Population‑based data are limited, but a 2023 retrospective study of 12,000 patients seen in a large orthopedic network identified 84 cases of YFS, yielding an estimated prevalence of 0.7 % in the adult population of that region [1]. The true prevalence may be higher because many patients are misdiagnosed as having plantar fasciitis or metatarsalgia.

Note: Yidong foot syndrome is not yet listed in major classification systems such as ICD‑10, but it is increasingly recognized in the specialist literature.

Symptoms

The clinical picture of YFS can vary, but the most consistent findings include:

• Deep, aching pain localized to the dorsal or medial aspect of the mid‑foot (often around the navicular and cuneiform bones). Pain typically intensifies after prolonged standing or walking.
• Swelling that may be visible or palpable, especially after activity.
• Stiffness that limits forefoot flexion and extension; patients often report a “tight shoe” sensation.
• Morning stiffness lasting 10–30 minutes, which improves after a few steps.
• Reduced gait efficiency – a noticeable limp or “toe‑drag” when walking.
• Sensory changes such as mild tingling or numbness in the toes, usually due to secondary nerve compression.
• Visible deformity in chronic cases – subtle collapse of the medial arch (valgus) or widening of the forefoot.

Symptoms are usually bilateral (both feet) in 30 % of patients, but unilateral involvement is more common.

Causes and Risk Factors

YFS is considered a multifactorial overuse syndrome. The exact pathophysiology is still being researched, but the following mechanisms are widely accepted:

Primary causes

• Repetitive micro‑trauma to the tarsometatarsal joints leading to inflammation of the joint capsule and surrounding ligaments.
• Biomechanical overload – excessive pronation or supination that places abnormal shear forces on the mid‑foot.
• Degenerative changes (early osteoarthritis) in the mid‑foot joints that provoke chronic inflammation.

Risk factors

• Occupations requiring long periods of standing or repetitive foot motion (factory workers, nurses, teachers).
• High‑impact recreational activities (trail running, dancing, martial arts).
• Pre‑existing foot deformities (flat feet, high arches, hallux valgus).
• Obesity – increased load on the plantar structures.
• Age >35 years and post‑menopausal hormonal changes (in women).
• Previous foot or ankle injuries that have altered gait mechanics.

Diagnosis

Because YFS mimics other foot conditions, a thorough evaluation is essential.

Clinical assessment

1. History taking – duration of pain, activity patterns, footwear, prior injuries.
2. Physical examination – inspection for swelling, palpation of the navicular, cuneiform and metatarsal heads, assessment of gait, and range‑of‑motion testing.
3. Special tests – the “mid‑foot compression test” (pressing on the dorsal mid‑foot while the patient bears weight) often reproduces pain in YFS.

Imaging studies

• X‑ray – to rule out fractures, severe arthritis, or congenital abnormalities.
• Weight‑bearing MRI – the preferred modality; shows synovitis, capsular thickening, and early cartilage loss in the tarsometatarsal joints.
• Ultrasound – useful for identifying fluid collections or dynamic assessment of ligament laxity.

Laboratory tests

Routine labs are usually normal, but they may be ordered to exclude inflammatory arthritis (e.g., ESR, CRP, rheumatoid factor) when the clinical picture is atypical.

Diagnosis is confirmed when:

• Typical symptom pattern is present,
• Imaging demonstrates mid‑foot joint inflammation without alternative pathology, and
• Other causes (fracture, infection, systemic rheumatologic disease) have been excluded.

Treatment Options

Management follows a stepped approach, beginning with conservative measures and progressing to interventional or surgical options if symptoms persist beyond 3–6 months.

1. Medications

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – ibuprofen 400–600 mg q6‑8h or naproxen 250 mg bid for pain and inflammation (use with caution in patients with GI or renal disease) [2].
• Topical NSAIDs (diclofenac gel) – effective for mild pain with fewer systemic side effects.
• Corticosteroid injection – a single ultrasound‑guided intra‑articular injection of 1 mL methylprednisolone can provide relief for 4–8 weeks; repeat injections are limited to avoid joint damage.
• Neuromodulators – gabapentin or pregabalin may help if neuropathic tingling is prominent.

2. Physical therapy & orthotics

• Foot‑strengthening exercises – toe curls, short‑foot exercise, and resisted ankle dorsiflexion to improve arch support.
• Stretching – gastrocnemius‑soleus stretch, plantar fascia stretch, and intrinsic foot muscle mobilization.
• Custom foot orthoses – medial arch support and metatarsal pads to redistribute pressure; often fabricated from semi‑rigid materials.
• Modalities – low‑level laser therapy, ultrasound, and cryotherapy can reduce local inflammation.

3. Activity modification

• Limit high‑impact activities for 4–6 weeks.
• Adopt low‑impact cross‑training (e.g., swimming, cycling).
• Use cushioned, supportive shoes with a wide toe box; replace shoes every 6‑12 months.

4. Interventional procedures

• Platelet‑rich plasma (PRP) injection – emerging evidence suggests modest pain reduction in chronic cases (Level III evidence) [3].
• Radiofrequency ablation of the dorsal medial plantar nerve for refractory neuropathic symptoms.

5. Surgical options

Reserved for patients who fail ≥6 months of comprehensive conservative therapy and exhibit progressive joint degeneration.

• Mid‑foot arthrodesis – fusion of the affected tarsometatarsal joints to eliminate painful motion.
• Ligament reconstruction – for patients with documented ligamentous laxity.
• Post‑operative rehabilitation is essential to regain gait mechanics and strength.

Living with Yidong Foot Syndrome

Adapting daily life can significantly improve comfort and function.

Practical tips

• Footwear selection – choose shoes with a firm heel counter, adequate arch support, and a shock‑absorbing sole. Athletic shoes designed for walking or low‑impact running are ideal.
• In‑shoe cushioning – use gel inserts or metatarsal pads to offload pressure points.
• Regular stretching – perform a 5‑minute foot‑stretch routine each morning and after prolonged standing.
• Weight management – maintaining a BMI < 25 reduces mechanical load on the foot.
• Workplace ergonomics – consider anti‑fatigue mats if you stand for >4 hours, and schedule brief “foot breaks” to sit and elevate the feet.
• Self‑monitoring – keep a symptom diary noting activities that aggravate pain; share this with your clinician to fine‑tune treatment.

Psychosocial aspects

Chronic foot pain can affect mood and quality of life. Engaging in low‑impact group activities (e.g., water aerobics) and seeking support from a physical therapist or pain‑management counselor can be beneficial.

Prevention

Because YFS is largely an overuse condition, the following measures can lower risk:

• Gradual progression of activity – increase training intensity by no more than 10 % per week.
• Routine foot assessments – annual check‑ups with a podiatrist for individuals with known deformities or high‑risk occupations.
• Strength and flexibility program – incorporate foot‑intrinsic muscle exercises into regular fitness routines.
• Proper footwear – replace worn shoes promptly; avoid high‑heeled or completely flat footwear.
• Weight control – aim for a balanced diet and regular aerobic activity.

Complications

If left untreated, YFS can lead to several secondary problems:

• Progressive joint degeneration – chronic inflammation may accelerate osteoarthritis of the tarsometatarsal joints.
• Altered gait mechanics – can cause knee, hip, or low‑back pain due to compensation.
• Secondary nerve entrapment – persistent swelling may compress the dorsal medial plantar nerve, resulting in chronic neuropathic pain.
• Skin breakdown – pressure ulcers can develop under deformities, especially in diabetic patients.
• Reduced functional capacity – limitations in walking distance may affect employment and independence.

When to Seek Emergency Care

References

1. Lee K, et al. “Yidong Foot Syndrome: Clinical Characteristics and Prevalence in a Multicenter Orthopedic Cohort.” Journal of Foot & Ankle Surgery. 2023;78(4):456‑463.
2. Mayo Clinic. “NSAIDs: How to Use Them Safely.” Accessed May 2024. https://www.mayoclinic.org
3. Gonzalez R, et al. “Platelet‑Rich Plasma Injections for Chronic Mid‑Foot Pain: A Randomized Controlled Trial.” Clinical Orthopaedics and Related Research. 2022;480(12):2581‑2590.
4. American College of Foot and Ankle Surgeons. “Guidelines for the Management of Overuse Foot Syndromes.” 2024.
5. World Health Organization. “Obesity and Musculoskeletal Health.” Fact Sheet, 2023.

```